Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Terret

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
British Journal of Cancer|July 17, 1999
CPT-11 converting carboxylesterase and topoisomerase activities in tumour and normal colon and liver tissuesS Guichard, C Terret, I Hennebelle, et al.
Cancer Treatment Reviews|September 28, 2021
Advanced oesophago-gastric adenocarcinoma in older patients in the era of immunotherapy. A review of the literatureC de la Fouchardiere, L Decoster, E Samalin, et al.
European Journal of Cancer (Oxford, England : 1990)|May 9, 2003
Phase I clinical and pharmacokinetic study of E7070, a novel sulfonamide given as a 5-day continuous infusion repeated every 3 weeks in patients with solid tumours. A study by the EORTC Early Clinical Study Group (ECSG)C Terret, S Zanetta, H Roché, et al.
Journal of Neuro-Oncology|February 24, 2001
Phase II trial of cystemustine, a new nitrosourea, as treatment of high-grade brain tumors in adultsH Roche, H Cure, A Adenis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 22, 2002
Pharmacokinetic study of cystemustine, administered on a weekly schedule in cancer patientsE Cellarier, C Terret, P Labarre, et al.
Critical Reviews in Oncology/Hematology|February 24, 2024
Patients' selection and trial matching in early-phase oncology clinical trialsP Corbaux, A Bayle, S Besle, et al.
British Journal of Cancer|October 29, 2002
Phase I study of docetaxel in combination with cyclophosphamide as first-line chemotherapy for metastatic breast cancerP A Vasey, H Roché, D Bisset, et al.
Clinical Pharmacology and Therapeutics|October 3, 2000
Dose and time dependencies of 5-fluorouracil pharmacokineticsC Terret, E Erdociain, R Guimbaud, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1996
Etoposide bioavailability after oral administration of the prodrug etoposide phosphate in cancer patients during a phase I studyG G Chabot, J P Armand, C Terret, et al.
European Journal of Cancer (Oxford, England : 1990)|October 15, 2003
Glufosfamide administered using a 1-hour infusion given as first-line treatment for advanced pancreatic cancer. A phase II trial of the EORTC-new drug development groupE Briasoulis, N Pavlidis, C Terret, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
British Journal of Cancer|July 17, 1999
CPT-11 converting carboxylesterase and topoisomerase activities in tumour and normal colon and liver tissuesS Guichard, C Terret, I Hennebelle, et al.
Cancer Treatment Reviews|September 28, 2021
Advanced oesophago-gastric adenocarcinoma in older patients in the era of immunotherapy. A review of the literatureC de la Fouchardiere, L Decoster, E Samalin, et al.
European Journal of Cancer (Oxford, England : 1990)|May 9, 2003
Phase I clinical and pharmacokinetic study of E7070, a novel sulfonamide given as a 5-day continuous infusion repeated every 3 weeks in patients with solid tumours. A study by the EORTC Early Clinical Study Group (ECSG)C Terret, S Zanetta, H Roché, et al.
Journal of Neuro-Oncology|February 24, 2001
Phase II trial of cystemustine, a new nitrosourea, as treatment of high-grade brain tumors in adultsH Roche, H Cure, A Adenis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 22, 2002
Pharmacokinetic study of cystemustine, administered on a weekly schedule in cancer patientsE Cellarier, C Terret, P Labarre, et al.
Critical Reviews in Oncology/Hematology|February 24, 2024
Patients' selection and trial matching in early-phase oncology clinical trialsP Corbaux, A Bayle, S Besle, et al.
British Journal of Cancer|October 29, 2002
Phase I study of docetaxel in combination with cyclophosphamide as first-line chemotherapy for metastatic breast cancerP A Vasey, H Roché, D Bisset, et al.
Clinical Pharmacology and Therapeutics|October 3, 2000
Dose and time dependencies of 5-fluorouracil pharmacokineticsC Terret, E Erdociain, R Guimbaud, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1996
Etoposide bioavailability after oral administration of the prodrug etoposide phosphate in cancer patients during a phase I studyG G Chabot, J P Armand, C Terret, et al.
European Journal of Cancer (Oxford, England : 1990)|October 15, 2003
Glufosfamide administered using a 1-hour infusion given as first-line treatment for advanced pancreatic cancer. A phase II trial of the EORTC-new drug development groupE Briasoulis, N Pavlidis, C Terret, et al.
Pageof 3